Dr. Jeanny B Aragon-Ching, MD, F.A.C.P.
Claim this profileInova Health Care Services
Area of expertise
Bladder Cancer
Jeanny B Aragon-Ching, MD, F.A.C.P. has run 2 trials for Bladder Cancer. Some of their research focus areas include:
Transitional Cell Carcinoma
Jeanny B Aragon-Ching, MD, F.A.C.P. has run 2 trials for Transitional Cell Carcinoma. Some of their research focus areas include:
Affiliated Hospitals
Inova Health Care Services
Inova Schar Cancer Institute
Clinical Trials Jeanny B Aragon-Ching, MD, F.A.C.P. is currently running
Disitamab Vedotin + Pembrolizumab vs Chemotherapy
for Bladder Cancer
This study will enroll participants with urothelial cancer (UC). UC can include cancer of the bladder, kidney, or the tubes that carry pee through the body (ureter, urethra). This study will try to find out if the drugs disitamab vedotin with pembrolizumab works better than platinum-containing chemotherapy to treat patients with UC. This study will also test what side effects happen when participants take these drugs together. A side effect is anything a drug does to the body besides treating the disease. Participants in this study will have cancer that has spread through the body (metastatic) or spread near where it started (locally advanced). In this study, there are 2 different groups. Participants will be assigned to a group randomly. Participants in the disitamab vedotin arm will get the study drug disitamab vedotin once every two weeks and pembrolizumab once every 6 weeks. Participants in the standard of care arm will get gemcitabine once a week for 2 weeks with either cisplatin or carboplatin once every 3 weeks.
Recruiting
2 awards
Phase 3
Disitamab Vedotin + Pembrolizumab
for Bladder Cancer
This trial is testing a new drug called disitamab vedotin, alone or with pembrolizumab, for patients with advanced or metastatic HER2 expressing bladder cancer. Disitamab vedotin is designed to target HER2 and has been approved for other types of cancer. The study aims to see if these drugs can effectively treat the cancer and what side effects they might cause.
Recruiting
1 award
Phase 2
4 criteria
More about Jeanny B Aragon-Ching, MD, F.A.C.P.
Clinical Trial Related
2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Jeanny B Aragon-Ching, MD, F.A.C.P. has experience with
- Disitamab Vedotin
- Pembrolizumab
- Carboplatin
- Cisplatin
- Gemcitabine
Breakdown of trials Jeanny B Aragon-Ching, MD, F.A.C.P. has run
Bladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeanny B Aragon-Ching, MD, F.A.C.P. specialize in?
Jeanny B Aragon-Ching, MD, F.A.C.P. focuses on Bladder Cancer and Transitional Cell Carcinoma. In particular, much of their work with Bladder Cancer has involved HER2 positive patients, or patients who are Stage III.
Is Jeanny B Aragon-Ching, MD, F.A.C.P. currently recruiting for clinical trials?
Yes, Jeanny B Aragon-Ching, MD, F.A.C.P. is currently recruiting for 2 clinical trials in Falls Church Virginia. If you're interested in participating, you should apply.
Are there any treatments that Jeanny B Aragon-Ching, MD, F.A.C.P. has studied deeply?
Yes, Jeanny B Aragon-Ching, MD, F.A.C.P. has studied treatments such as Disitamab Vedotin, Pembrolizumab, Carboplatin.
What is the best way to schedule an appointment with Jeanny B Aragon-Ching, MD, F.A.C.P.?
Apply for one of the trials that Jeanny B Aragon-Ching, MD, F.A.C.P. is conducting.
What is the office address of Jeanny B Aragon-Ching, MD, F.A.C.P.?
The office of Jeanny B Aragon-Ching, MD, F.A.C.P. is located at: Inova Health Care Services, Falls Church, Virginia 22042 United States. This is the address for their practice at the Inova Health Care Services.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.